Rowe, I. A., Houlihan, D. D., & Mutimer, D. J. (2012). Despite poor interferon response in advanced hepatitis C virus infection, models of protease inhibitor treatment predict maximum treatment benefit. Alimentary pharmacology & therapeutics, 36(7), 670-679. https://doi.org/10.1111/apt.12018
Chicago Style (17th ed.) CitationRowe, I. A., D. D. Houlihan, and D. J. Mutimer. "Despite Poor Interferon Response in Advanced Hepatitis C Virus Infection, Models of Protease Inhibitor Treatment Predict Maximum Treatment Benefit." Alimentary Pharmacology & Therapeutics 36, no. 7 (2012): 670-679. https://doi.org/10.1111/apt.12018.
MLA (9th ed.) CitationRowe, I. A., et al. "Despite Poor Interferon Response in Advanced Hepatitis C Virus Infection, Models of Protease Inhibitor Treatment Predict Maximum Treatment Benefit." Alimentary Pharmacology & Therapeutics, vol. 36, no. 7, 2012, pp. 670-679, https://doi.org/10.1111/apt.12018.